The Need to Take a Staging Approach to the Biological Mechanisms of PTSD and its Treatment

Current Psychiatry Reports

Volumn 19, Issue 2, 2017, Pages

  McFarlane, Alexander Cowell ^a   Lawrence Wood, Eleanor ^a   Van Hooff, Miranda ^a   Malhi, Gin S ^b   Yehuda, Rachel ^c  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Delayed onset; Duration of illness; Inflammation; Longitudinal course; Medical comorbidity; Neurobiology; PTSD; Staging; Subsyndromal; Treatment

Indexed keywords

KETAMINE; OXYTOCIN; SUBSTANCE P ANTAGONIST;

ACUTE DISEASE; AUTOIMMUNE DISEASE; BIOLOGICAL THERAPY; CARDIOVASCULAR DISEASE; CHRONIC INFLAMMATION; CLINICAL EFFECTIVENESS; COMORBIDITY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; EVIDENCE BASED MEDICINE; HUMAN; IMMUNOPATHOLOGY; MENTAL STRESS; METABOLIC DISORDER; MILITARY SERVICE; NEUROBIOLOGY; PATHOPHYSIOLOGY; POSTTRAUMATIC STRESS DISORDER; PROBABILITY; PROSPECTIVE STUDY; PSYCHOTHERAPY; PSYCHOTRAUMA; REVIEW; RISK ASSESSMENT; RISK FACTOR; SYSTEMIC DISEASE; TRANSCRANIAL MAGNETIC STIMULATION; CLASSIFICATION; COMBAT DISORDERS; INFLAMMATION; LONGITUDINAL STUDY; PSYCHOLOGY; PSYCHOPHYSIOLOGY; SOLDIER; STRESS DISORDERS, POST-TRAUMATIC;

ACUTE DISEASE; COMBAT DISORDERS; COMORBIDITY; DISEASE PROGRESSION; HUMANS; INFLAMMATION; LONGITUDINAL STUDIES; MILITARY PERSONNEL; PROSPECTIVE STUDIES; PSYCHOPHYSIOLOGY; RISK FACTORS; STRESS DISORDERS, POST-TRAUMATIC;

EID: 85011842127     PISSN: 15233812     EISSN: 15351645     Source Type: Journal    
DOI: 10.1007/s11920-017-0761-2     Document Type: Review

References (80)

1. Australian Centre for Posttraumatic Mental Health. Australian Guidelines for the Treatment of Acute Stress Disorder and Posttraumatic Stress Disorder. ACPMH. 2007.
2. • Yehuda R, Hoge CW, McFarlane AC, Vermetten E, Lanius RA, Nievergelt CM, et al. Post-traumatic stress disorder. Nat Rev Dis Primers. 2015;1:15057. This paper represents a comprehensive overview of the spectrum of neurobiology that underpins PTSD and highlights biological domains for advances in the treatment.
3. Pitman RK, Rasmusson AM, Koenen KC, Shin LM, Orr SP, Gilbertson MW, et al. Biological studies of post-traumatic stress disorder. Nat Rev Neurosci. 2012;13(11):769–87.
4. Steenkamp MM, Litz BT, Hoge CW, Marmar CR. Psychotherapy for military-related PTSD: a review of randomized clinical trials. JAMA. 2015;314(5):489–500.
5. Davis LL, English BA, Ambrose SM, Petty F. Pharmacotherapy for post-traumatic stress disorder: a comprehensive review. Expert Opin Pharmacother. 2001;2(10):1583–95.
6. Morina N, Wicherts JM, Lobbrecht J, Priebe S. Remission from post-traumatic stress disorder in adults: a systematic review and meta-analysis of long term outcome studies. Clin Psychol Rev. 2014;34(3):249–55.
7. • McGorry P, Keshavan M, Goldstone S, Amminger P, Allott K, Berk M, et al. Biomarkers and clinical staging in psychiatry. World Psychiatry. 2014;13(3):211–23. An excellent description of the staging approach and the disadvantages of current classification systems that do not address the progression of neurobiology in disorder.
8. Verduijn J, Milaneschi Y, van Hemert AM, Schoevers RA, Hickie IB, Penninx BW, et al. Clinical staging of major depressive disorder: an empirical exploration. J Clin Psychiatry. 2015;76(9):1200–8.
9. Gonnella JS, Hornbrook MC, Louis DZ. Staging of disease. A case-mix measurement. JAMA. 1984;251(5):637–44.
10. McGorry PD, Hickie IB, Yung AR, Pantelis C, Jackson HJ. Clinical staging of psychiatric disorders: a heuristic framework for choosing earlier, safer and more effective interventions. Aust N Z J Psychiatry. 2006;40(8):616–22.
11. Jones E, Wessely S. A paradigm shift in the conceptualization of psychological trauma in the 20th century. J Anxiety Disord. 2007;21(2):164–75.
12. Maercker A, Brewin CR, Bryant RA, Cloitre M, van Ommeren M, Jones LM, et al. Diagnosis and classification of disorders specifically associated with stress: proposals for ICD-11. World Psychiatry. 2013;12(3):198–206.
13. Yehuda R, McFarlane AC, Shalev AY. Predicting the development of posttraumatic stress disorder from the acute response to a traumatic event. Biol Psychiatry. 1998;44(12):1305–13.
14. Galatzer-Levy IR, Karstoft KI, Statnikov A, Shalev AY. Quantitative forecasting of PTSD from early trauma responses: a machine learning application. J Psychiatr Res. 2014;59:68–76.
15. Pettit JW, Lewinsohn PM, Roberts RE, Seeley JR, Monteith L. The long-term course of depression: development of an empirical index and identification of early adult outcomes. Psychol Med. 2009;39(3):403–12.
16. Dell’Osso B, Buoli M, Hollander E, Altamura AC. Duration of untreated illness as a predictor of treatment response and remission in obsessive-compulsive disorder. World J Biol Psychiatry. 2010;11(1):59–65.
17. Maguen S, Madden E, Neylan TC, Cohen BE, Bertenthal D, Seal KH. Timing of mental health treatment and PTSD symptom improvement among Iraq and Afghanistan veterans. Psychiatr Serv. 2014;65(12):1414–9.
18. Koek RJ, Schwartz HN, Scully S, Langevin JP, Spangler S, Korotinsky A, et al. Treatment-refractory posttraumatic stress disorder (TRPTSD): a review and framework for the future. Prog Neuropsychopharmacol Biol Psychiatry. 2016;70:170–218.
19. van Rooij SJ, Kennis M, Vink M, Geuze E. Predicting treatment outcome in PTSD: a longitudinal functional MRI study on trauma-unrelated emotional processing. Neuropsychopharmacology. 2016;41(4):1156–65.
20. Lobo I, Portugal LC, Figueira I, Volchan E, David I, Garcia Pereira M, et al. EEG correlates of the severity of posttraumatic stress symptoms: a systematic review of the dimensional PTSD literature. J Affect Disord. 2015;183:210–20.
21. Kaczkurkin AN, Burton PC, Chazin SM, Manbeck AB, Espensen-Sturges T, Cooper SE, Sponheim SR, Lissek S. Neural substrates of overgeneralized conditioned fear in PTSD. Am J Psychiatry. 2016:appiajp201615121549.
22. Fetzner MG, McMillan KA, Asmundson GJ. Similarities in specific physical health disorder prevalence among formerly deployed Canadian forces veterans with full and subsyndromal PTSD. Depress Anxiety. 2012;29(11):958–65.
23. Schmidt U. A plea for symptom-based research in psychiatry. Eur J Psychotraumatol. 2015. doi:10.3402/ejpt.v6.27660.
24. Pietrzak RH, Goldstein MB, Malley JC, Johnson DC, Southwick SM. Subsyndromal posttraumatic stress disorder is associated with health and psychosocial difficulties in veterans of Operations Enduring Freedom and Iraqi Freedom. Depress Anxiety. 2009;26(8):739–44.
25. Marshall RD, Olfson M, Hellman F, Blanco C, Guardino M, Struening EL. Comorbidity, impairment, and suicidality in subthreshold PTSD. Am J Psychiatry. 2001;158(9):1467–73.
26. Pietrzak RH, Feder A, Singh R, Schechter CB, Bromet EJ, Katz CL, et al. Trajectories of PTSD risk and resilience in World Trade Center responders: an 8-year prospective cohort study. Psychol Med. 2014;44(1):205–19.
27. Halpern J, Maunder RG, Schwartz B, Gurevich M. Identifying risk of emotional sequelae after critical incidents. Emerg Med J. 2011;28(1):51–6.
28. Schür RR, Boks MP, Geuze E, Prinsen HC, Verhoeven-Duif NM, Joëls M, et al. Development of psychopathology in deployed armed forces in relation to plasma GABA levels. Psychoneuroendocrinology. 2016;73:263–70.
29. Steudte-Schmiedgen S, Stalder T, Schönfeld S, Wittchen HU, Trautmann S, Alexander N, et al. Hair cortisol concentrations and cortisol stress reactivity predict PTSD symptom increase after trauma exposure during military deployment. Psychoneuroendocrinology. 2015;59:123–33.
30. van Zuiden M, Kavelaars A, Vermetten E, Olff M, Geuze E, Heijnen C. Pre-deployment differences in glucocorticoid sensitivity of leukocytes in soldiers developing symptoms of PTSD, depression or fatigue persist after return from military deployment. Psychoneuroendocrinology. 2015;51:513–24.
31. Vermetten E, Baker D, Yehuda R. New findings from prospective studies. Psychoneuroendocrinology. 2015;51:441–3.
32. Wiborg JF, Rademaker AR, Geuze E, Twisk JW, Vermetten E, Knoop H. Course and predictors of postdeployment fatigue: a prospective cohort study in the Dutch Armed Forces. J Clin Psychiatry. 2016;77(8):1074–9.
33. • Bryant RA, Nickerson A, Creamer M, O’Donnell M, Forbes D, Galatzer-Levy I, et al. Trajectory of post-traumatic stress following traumatic injury: 6-year follow-up. Br J Psychiatry. 2015;206(5):417–23. The long period of observation of this cohort demonstrates the unexpected prevalence of delayed onset PTSD that many studies with shorter periods of follow up miss which need addressing in causal models.
34. O’Donnell ML, Varker T, Creamer M, Fletcher S, McFarlane AC, Silove D, et al. Exploration of delayed-onset posttraumatic stress disorder after severe injury. Psychosom Med. 2013;75(1):68–75.
35. Inslicht SS, Otte C, McCaslin SE, Apfel BA, Henn-Haase C, Metzler T, et al. Cortisol awakening response prospectively predicts peritraumatic and acute stress reactions in police officers. Biol Psychiatry. 2011;70(11):1055–62.
36. Smid GE, van Zuiden M, Geuze E, Kavelaars A, Heijnen CJ, Vermetten E. Cytokine production as a putative biological mechanism underlying stress sensitization in high combat exposed soldiers. Psychoneuroendocrinology. 2015;51:534–46.
37. Smid GE, Kleber RJ, Rademaker AR, van Zuiden M, Vermetten E. The role of stress sensitization in progression of posttraumatic distress following deployment. Soc Psychiatry Psychiatr Epidemiol. 2013;48(11):1743–54.
38. Karam EG, Friedman MJ, Hill ED, Kessler RC, McLaughlin KA, Petukhova M, et al. Cumulative traumas and risk thresholds:12-month PTSD in the World Mental Health (WMH) surveys. Depress Anxiety. 2014;31(2):130–42.
39. Harvey SB, Milligan-Saville JS, Paterson HM, Harkness EL, Marsh AM, Dobson M, et al. The mental health of fire-fighters: an examination of the impact of repeated trauma exposure. Aust N Z J Psychiatry. 2016;50(7):649–58.
40. Bonanno GA, Mancini AD, Horton JL, Powell TM, Leardmann CA, Boyko EJ, et al. Trajectories of trauma symptoms and resilience in deployed U.S. military service members: prospective cohort study. Br J Psychiatry. 2012;200(4):317–23.
41. Minassian A, Maihofer AX, Baker DG, Nievergelt CM, Geyer MA, Risbrough VB, et al. Association of predeployment heart rate variability with risk of postdeployment posttraumatic stress disorder in active-duty marines. JAMA Psychiatry. 2015;72(10):979–86.
42. Breen MS, Maihofer AX, Glatt SJ, Tylee DS, Chandler SD, Tsuang MT, et al. Gene networks specific for innate immunity define post-traumatic stress disorder. Mol Psychiatry. 2015;20(12):1538–45.
43. Costanzo M, Jovanovic T, Norrholm SD, Ndiongue R, Reinhardt B, Roy MJ. Psychophysiological investigation of combat veterans with subthreshold post-traumatic stress disorder symptoms. Mil Med. 2016;181(8):793–802.
44. Keane TM, Kolb LC, Kaloupek DG, Orr SP, Blanchard EB, Thomas RG, et al. Utility of psychophysiological measurement in the diagnosis of posttraumatic stress disorder: results from a Department of Veterans Affairs Cooperative Study. J Consult Clin Psychol. 1998;66(6):914–23.
45. Levy-Gigi E, Richter-Levin G, Kéri S. The hidden price of repeated traumatic exposure: different cognitive deficits in different first-responders. Front Behav Neurosci. 2014;8:281.
46. Levy-Gigi E, Szabo C, Richter-Levin G, Kéri S. Reduced hippocampal volume is associated with overgeneralization of negative context in individuals with PTSD. Neuropsychology. 2015;29(1):151–61.
47. Covey TJ, Shucard JL, Violanti JM, Lee J, Shucard DW. The effects of exposure to traumatic stressors on inhibitory control in police officers: a dense electrode array study using a Go/NoGo continuous performance task. Int J Psychophysiol. 2013;87(3):363–75.
48. • Yehuda R, Flory JD, Bierer LM, Henn-Haase C, Lehrner A, Desarnaud F, et al. Lower methylation of glucocorticoid receptor gene promoter 1F in peripheral blood of veterans with posttraumatic stress disorder. Biol Psychiatry. 2015;77(4):356–64. The epigenetic mechanisms of glucocorticoid sensitivity is a central to understanding the emerging shifts in the neurobiology of the stress response that underpin PTSD.
49. Eraly SA, Nievergelt CM, Maihofer AX, Barkauskas DA, Biswas N, Agorastos A, et al. Assessment of plasma C-reactive protein as a biomarker of posttraumatic stress disorder risk. JAMA Psychiatry. 2014;71(4):423–31.
50. Bryant RA, Creamer M, O’Donnell M, Silove D, McFarlane AC, Forbes D. A comparison of the capacity of DSM-IV and DSM-5 acute stress disorder definitions to predict posttraumatic stress disorder and related disorders. J Clin Psychiatry. 2015;76(4):391–7.
51. Kessler RC, Sonnega A, Bromet E, Hughes M, Nelson CB. Posttraumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry. 1995;52(12):1048–60.
52. Hruska B, Irish LA, Pacella ML, Sledjeski EM, Delahanty DL. PTSD symptomseverity and psychiatric comorbidity in recent motor vehicle accident victims: a latent class analysis. J Anxiety Disord. 2014;28(7):644–9.
53. Conway CR, George MS, Sackeim HA. Toward an evidence-based, operational definition of treatment-resistant depression: when enough is enough. JAMA Psychiatry. 2016. doi:10.1001/jamapsychiatry.2016.2586.
54. Lissek S, van Meurs B. Learning models of PTSD: theoretical accounts and psychobiological evidence. Int J Psychophysiol. 2015;98(3 Pt 2):594–605.
55. Michopoulos V, Powers A, Gillespie CF, Ressler KJ, Jovanovic T. Inflammation in fear- and anxiety-based disorders: PTSD, GAD, and beyond. Neuropsychopharmacology. 2016. doi:10.1038/npp.2016.146.
56. McFarlane AC. The long-term costs of traumatic stress: intertwined physical and psychological consequences. World Psychiatry. 2010;9(1):3–10.
57. Michopoulos V, Rothbaum AO, Jovanovic T, Almli LM, Bradley B, Rothbaum BO, et al. Association of CRP genetic variation and CRP level with elevated PTSD symptoms and physiological responses in a civilian population with high levels of trauma. Am J Psychiatry. 2015;172(4):353–62.
58. Michopoulos V, Vester A, Neigh G. Posttraumatic stress disorder: a metabolic disorder in disguise? Exp Neurol. 2016;284(Pt B):220–9.
59. Gola H, Engler H, Sommershof A, Adenauer H, Kolassa S, Schedlowski M, et al. Posttraumatic stress disorder is associated with an enhanced spontaneous production of pro-inflammatory cytokines by peripheral blood mononuclear cells. BMC Psychiatry. 2013. doi:10.1186/1471-244×-13-40.
60. Heinzelmann M, Gill J. Epigenetic mechanisms shape the biological response to trauma and risk for PTSD: a critical review. Nurs Res Pract. 2013. doi:10.1155/2013/417010.
61. Kardiner A. The traumatic neuroses of war. National Academies; 1941.
62. Kolb LC. A perspective and future dreams of PTSD as a psychosomatic disorder. Psychosom Med. 1993;55(5):424–5.
63. Lohr JB, Palmer BW, Eidt CA, Aailaboyina S, Mausbach BT, Wolkowitz OM, et al. Is post-traumatic stress disorder associated with premature senescence? A review of the Literature. Am J Geriatr Psychiatry. 2015;23(7):709–25.
64. Pacella ML, Hruska B, Delahanty DL. The physical health consequences of PTSD and PTSD symptoms: a meta-analytic review. J Anxiety Disord. 2013;27(1):33–46.
65. • Daskalakis NP, Cohen H, Nievergelt CM, Baker DG, Buxbaum JD, Russo SJ, et al. New translational perspectives for blood-based biomarkers of PTSD: from glucocorticoid to immune mediators of stress susceptibility. Exp Neurol. 2016;284(Pt B):133–40. An important paper setting out the emerging therapeutic possibilities and the interactions between the glucocorticoid system and immunological reactivity.
66. Rosenbaum S, Stubbs B, Ward PB, Steel Z, Lederman O, Vancampfort D. The prevalence and risk of metabolic syndrome and its components among people with posttraumatic stress disorder: a systematic review and meta-analysis. Metabolism. 2015;64(8):926–33.
67. Sumner JA, Kubzansky LD, Roberts AL, Gilsanz P, Chen Q, Winning A, et al. Post-traumatic stress disorder symptoms and risk of hypertension over 22 years in a large cohort of younger and middle-aged women. Psychol Med. 2016;46(15):3105–16.
68. Burg MM, Soufer R. Post-traumatic stress disorder and cardiovascular disease. Curr Cardiol Rep. 2016. doi:10.1007/s11886-016-0770-5.
69. Schlenger WE, Corry NH, Williams CS, Kulka RA, Mulvaney-Day N, DeBakey S, et al. A prospective study of mortality and trauma-related risk factors among a nationally representative sample of Vietnam veterans. Am J Epidemiol. 2015;182(12):980–90.
70. Jergović M, Tomičević M, Vidović A, Bendelja K, Savić A, Vojvoda V, et al. Telomere shortening and immune activity in war veterans with posttraumatic stress disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2014;54:275–83.
71. Lindqvist D, Dhabhar FS, Mellon SH, Yehuda R, Grenon SM, Flory JD, et al. Increased pro-inflammatory milieu in combat related PTSD—a new cohort replication study. Brain Behav Immun. 2016. doi:10.1016/j.bbi.2016.09.012.
72. • O’Donovan A, Cohen BE, Seal KH, Bertenthal D, Margaretten M, Nishimi K, et al. Elevated risk for autoimmune disorders in Iraq and Afghanistan veterans with posttraumatic stress disorder. Biol Psychiatry. 2015;77(4):365–74. A large cohort study sufficiently powered to highlight the burden of immunological dysregulation in PTSD on the prevalence of autoimmune disorders.
73. Stein MB, Chen CY, Ursano RJ, Cai T, Gelernter J, Heeringa SG, et al. Genome-wide association studies of posttraumatic stress disorder in 2 cohorts of US Army soldiers. JAMA Psychiatry. 2016;73(7):695–704.
74. Sussman D, Pang EW, Jetly R, Dunkley BT, Taylor MJ. Neuroanatomical features in soldiers with post-traumatic stress disorder. BMC Neurosci. 2016. doi:10.1186/s12868-016-0247-x.
75. O’Doherty DC, Chitty KM, Saddiqui S, Bennett MR, Lagopoulos J. A systematic review and meta-analysis of magnetic resonance imaging measurement of structural volumes in posttraumatic stress disorder. Psychiatry Res. 2015;232(1):1–33.
76. Hedges DW, Woon FL. Premorbid brain volume estimates and reduced total brain volume in adults exposed to trauma with or without posttraumatic stress disorder: a meta-analysis. Cog Behav Nurol. 2010;23(2):124–9.
77. Shucard JL, Cox J, Shucard DW, Fetter H, Chung C, Ramasamy D, et al. Symptoms of posttraumatic stress disorder and exposure to traumatic stressors are related to brain structural volumes and behavioral measures of affective stimulus processing in police officers. Psychiatry Res. 2012;204(1):25–31.
78. Howlett JR, Stein MB. Prevention of trauma and stressor-related disorders: a review. Neuropsychopharmacology. 2016;41(1):357–69.
79. Michopoulos V, Jovanovic T. Chronic inflammation: a new therapeutic target for post-traumatic stress disorder? Lancet Psychiatry. 2015;2(11):954–5.
80. Pitman RK. Overview of biological themes in PTSD. Ann NY Acad Sci. 1997;821:1–9.